206 related articles for article (PubMed ID: 35979992)
21. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
22. Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers.
Tsoi TT; Chiu KWH; Chu MY; Ngan HYS; Lee EYP
J Ovarian Res; 2020 May; 13(1):61. PubMed ID: 32434520
[TBL] [Abstract][Full Text] [Related]
23.
Vallius T; Hynninen J; Kemppainen J; Alves V; Auranen K; Matomäki J; Oksa S; Virtanen J; Grénman S; Auranen A; Seppänen M
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1224-1232. PubMed ID: 29476227
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
[TBL] [Abstract][Full Text] [Related]
25. Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.
Bojaxhiu B; Sinovcic D; Elicin O; Templeton AJ; Shelan M; Wartenberg J; Alberts I; Rominger A; Aebersold DM; Zaugg K
Radiat Oncol; 2022 Aug; 17(1):141. PubMed ID: 35964056
[TBL] [Abstract][Full Text] [Related]
26. F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer.
Gallicchio R; Nardelli A; Venetucci A; Capacchione D; Pelagalli A; Sirignano C; Mainenti P; Pedicini P; Guglielmi G; Storto G
Eur J Radiol; 2017 Aug; 93():107-113. PubMed ID: 28668403
[TBL] [Abstract][Full Text] [Related]
27. Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer.
Liu S; Feng Z; Jiang Z; Wen H; Xu J; Pan H; Deng Y; Zhang L; Ju X; Chen X; Wu X
Nucl Med Commun; 2018 Oct; 39(10):928-935. PubMed ID: 29771717
[TBL] [Abstract][Full Text] [Related]
28. Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer.
Chung YS; Kim HS; Lee JY; Kang WJ; Nam EJ; Kim S; Kim SW; Kim YT
Cancer Res Treat; 2020 Oct; 52(4):1211-1218. PubMed ID: 32599990
[TBL] [Abstract][Full Text] [Related]
29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer.
Chung YS; Kim Y; Kim HS; Lee JY; Kang WJ; Kim S; Kim SW
J Gynecol Oncol; 2022 May; 33(3):e28. PubMed ID: 35128858
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implication of the metastatic lesion-to-ovarian cancer standardised uptake value ratio in advanced serous epithelial ovarian cancer.
Chung HH; Lee M; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Eur Radiol; 2017 Nov; 27(11):4510-4515. PubMed ID: 28593431
[TBL] [Abstract][Full Text] [Related]
32. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
[TBL] [Abstract][Full Text] [Related]
33. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancer.
Kim J; Gil J; Kim SI; Hwangbo S; Noh JJ; Lee JW; Cheon GJ; Kim JW; Cho YS; Lee M
Clin Nucl Med; 2023 Feb; 48(2):e51-e59. PubMed ID: 36607373
[TBL] [Abstract][Full Text] [Related]
35. Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.
Chung HH; Kim JW; Park NH; Song YS; Cheon GJ
Eur Radiol; 2018 May; 28(5):2107-2114. PubMed ID: 29260365
[TBL] [Abstract][Full Text] [Related]
36. The maximum standardized uptake value and extent of peritoneal involvement may predict the prognosis of patients with recurrent ovarian cancer after primary treatment: A retrospective clinical study.
Jiang Y; Hou G; Wu F; Zhu Z; Zhang W; Cheng W
Medicine (Baltimore); 2020 Feb; 99(8):e19228. PubMed ID: 32080121
[TBL] [Abstract][Full Text] [Related]
37. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
[TBL] [Abstract][Full Text] [Related]
38. [18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation?
Dondi F; Albano D; Bertagna F; Giubbini R
Nucl Med Rev Cent East Eur; 2022; 25(2):78-84. PubMed ID: 35848529
[TBL] [Abstract][Full Text] [Related]
39. The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma.
Ye S; Liu S; Zhou S; Xiang L; Wu X; Yang H
Cancer Biomark; 2020; 27(2):189-194. PubMed ID: 31796665
[TBL] [Abstract][Full Text] [Related]
40. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
